MONDAY, May 11, 2026 The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the bile ducts. B
FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer MedNews
Latest from Blog
Opinion: RFK Jr.’s antidepressant deprescribing push gets one thing right — and others dangerously wrong
I recently helped a woman in her early 60s taper off fluoxetine (often known by the brand name Prozac), which she had taken for over 35 years, followed by bupropion (aka Wellbutrin),
Opinion: Access to air conditioning is critical preventive care. But federal policy treats it as optional
During the first heat wave of 2025, 55-year-old Shauna Thomas was found dead in her suburban St. Louis apartment after spending at least three days without air conditioning or water. Police said
STAT+: Bill Cassidy risked his legacy. It may not be enough to save his career
BATON ROUGE, La. — When it comes to Bill Cassidy, most everyone in Louisiana politics — supporters and detractors alike — feels bad for the senator. For his 20 years in politics,
STAT+: A new kind of liver crisis is emerging in the U.S. The American diet is to blame
The United States is hardly the only country where heavy and binge drinking is a problem. But Americans face a unique crisis: This country’s obesity and diabetes epidemics, combined with heavy alcohol use,
Herbalife and Cristiano Ronaldo Bring Performance Nutrition to Everyday Routines with “Fuel Like Ronaldo” Campaign
/PRNewswire/ — Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, announced the launch of its “Fuel Like Ronaldo”… Post Views: 3